WO1998010292A1 - Anticorps monoclonaux contre l'antigene prostatique specifique et procedes de detection de l'antigene prostatique specifique - Google Patents

Anticorps monoclonaux contre l'antigene prostatique specifique et procedes de detection de l'antigene prostatique specifique Download PDF

Info

Publication number
WO1998010292A1
WO1998010292A1 PCT/US1997/014909 US9714909W WO9810292A1 WO 1998010292 A1 WO1998010292 A1 WO 1998010292A1 US 9714909 W US9714909 W US 9714909W WO 9810292 A1 WO9810292 A1 WO 9810292A1
Authority
WO
WIPO (PCT)
Prior art keywords
monoclonal antibody
specific antigen
prostate specific
amino acids
seq
Prior art date
Application number
PCT/US1997/014909
Other languages
English (en)
Inventor
George A. Heavner
Original Assignee
Centocor, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centocor, Inc. filed Critical Centocor, Inc.
Priority to AU40863/97A priority Critical patent/AU4086397A/en
Publication of WO1998010292A1 publication Critical patent/WO1998010292A1/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57434—Specifically defined cancers of prostate
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Oncology (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hospice & Palliative Care (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

La présente invention concerne des anticorps monoclonaux utilisés dans la détection de l'antigène prostatique spécifique. Plusieurs anticorps monoclonaux lient l'antigène prostatique spécifique libre et lié, et un des anticorps monoclonaux lie l'antigène prostatique spécifique. Cette invention concerne également des procédés de détection du cancer tel que le cancer de la prostate.
PCT/US1997/014909 1996-09-06 1997-08-25 Anticorps monoclonaux contre l'antigene prostatique specifique et procedes de detection de l'antigene prostatique specifique WO1998010292A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU40863/97A AU4086397A (en) 1996-09-06 1997-08-25 Monoclonal antibodies specific for prostate specific antigen and methods of detecting prostate specific antigen

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2540496P 1996-09-06 1996-09-06
US60/025,404 1996-09-06

Publications (1)

Publication Number Publication Date
WO1998010292A1 true WO1998010292A1 (fr) 1998-03-12

Family

ID=21825864

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/014909 WO1998010292A1 (fr) 1996-09-06 1997-08-25 Anticorps monoclonaux contre l'antigene prostatique specifique et procedes de detection de l'antigene prostatique specifique

Country Status (2)

Country Link
AU (1) AU4086397A (fr)
WO (1) WO1998010292A1 (fr)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0947832A1 (fr) * 1998-04-03 1999-10-06 Roche Diagnostics GmbH Procédé immunologique de détermination de PSA
WO1999065523A1 (fr) * 1998-06-15 1999-12-23 Altarex Corp. Composition et methode immunotherapeutiques de traitement du cancer de la prostate
WO2000066718A1 (fr) * 1999-04-30 2000-11-09 Hybritech Incorporated Formes de l'antigene prostatique specifique (aps) specifiques a l'hyperplasie prostatique benigne (hpb) et procedes de leur utilisation
FR2813394A1 (fr) * 2000-08-25 2002-03-01 Urogene Procede de dosage de l'antigene specifique de la prostate, procede de diagnostic in vitro du cancer de la prostate, et kits pour la mise en oeuvre de ces procedes
US11365234B2 (en) 2015-03-27 2022-06-21 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
AU2020256298B2 (en) * 2015-03-27 2022-07-14 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors
AU2021202060B2 (en) * 2015-08-05 2023-06-15 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001936A1 (fr) * 1990-07-23 1992-02-06 Hans Lilja Analyse de l'antigene specifique de la prostate (psa) a l'etat libre et a l'etat formant complexe
WO1995003334A1 (fr) * 1993-07-22 1995-02-02 Mayo Foundation For Medical Education And Research Anticorps specifiques contre la kallicreine glandulaire humaine de la prostate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992001936A1 (fr) * 1990-07-23 1992-02-06 Hans Lilja Analyse de l'antigene specifique de la prostate (psa) a l'etat libre et a l'etat formant complexe
WO1995003334A1 (fr) * 1993-07-22 1995-02-02 Mayo Foundation For Medical Education And Research Anticorps specifiques contre la kallicreine glandulaire humaine de la prostate

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
CLINICAL CHEMISTRY, April 1997, Vol. 43, No .4, COREY et al., "Prostate-Specific Antigen: Characterization of Epitopes by Synthetic Peptide Mapping and Inhibition Studies", pages 575-584. *
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1994, Vol. 220, CHRISTENSSON et al., "Complex Formation Between Protein C Inhibitor and Prostate-Specific Antigen In Vitro and in Human Semen", pages 45-53. *
PROTEIN SCIENCE, May 1996, Vol. 5, VILLOUTREIX et al., "Structural Investigation of the Alpha-I-Antichymotrypsin: Prostate-Specific Antigen Complex by Comparative Model Building", pages 836-851. *

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0947832A1 (fr) * 1998-04-03 1999-10-06 Roche Diagnostics GmbH Procédé immunologique de détermination de PSA
US6361955B1 (en) 1998-04-03 2002-03-26 Roche Diagnostics Gmbh Immunological process for PSA determination
WO1999065523A1 (fr) * 1998-06-15 1999-12-23 Altarex Corp. Composition et methode immunotherapeutiques de traitement du cancer de la prostate
US6881405B2 (en) 1998-06-15 2005-04-19 Altarex Medical Corp. Reagents and methods for inducing an immune response to prostate specific antigen
US7579445B2 (en) 1998-06-15 2009-08-25 Altarex Medical Corp. Reagents and methods for inducing an immune response to prostate specific antigen
WO2000066718A1 (fr) * 1999-04-30 2000-11-09 Hybritech Incorporated Formes de l'antigene prostatique specifique (aps) specifiques a l'hyperplasie prostatique benigne (hpb) et procedes de leur utilisation
FR2813394A1 (fr) * 2000-08-25 2002-03-01 Urogene Procede de dosage de l'antigene specifique de la prostate, procede de diagnostic in vitro du cancer de la prostate, et kits pour la mise en oeuvre de ces procedes
US11407809B2 (en) 2015-03-27 2022-08-09 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11440947B2 (en) 2015-03-27 2022-09-13 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
AU2020256298B2 (en) * 2015-03-27 2022-07-14 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against various tumors
US11407808B2 (en) 2015-03-27 2022-08-09 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11407807B2 (en) 2015-03-27 2022-08-09 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11365234B2 (en) 2015-03-27 2022-06-21 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11407810B2 (en) 2015-03-27 2022-08-09 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11434274B2 (en) 2015-03-27 2022-09-06 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11434273B2 (en) 2015-03-27 2022-09-06 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11365235B2 (en) 2015-03-27 2022-06-21 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11459371B2 (en) 2015-03-27 2022-10-04 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11466072B2 (en) 2015-03-27 2022-10-11 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11965013B2 (en) 2015-03-27 2024-04-23 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11702460B2 (en) 2015-03-27 2023-07-18 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11873329B2 (en) 2015-03-27 2024-01-16 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
US11897934B2 (en) 2015-03-27 2024-02-13 Immatics Biotechnologies Gmbh Peptides and combination of peptides for use in immunotherapy against various tumors
AU2021202060B2 (en) * 2015-08-05 2023-06-15 Immatics Biotechnologies Gmbh Novel peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers

Also Published As

Publication number Publication date
AU4086397A (en) 1998-03-26

Similar Documents

Publication Publication Date Title
AU693457B2 (en) Antibodies specific for human prostate glandular kallikrein
AU2008202992B2 (en) Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
US6143509A (en) Prostate specific antigen peptides and uses thereof
US6482599B1 (en) Forms of prostate specific antigen (PSA) specific for benign prostatic hyperplasia (BPH) and methods of using such
US5501988A (en) Anti hCG-β core monoclonal antibody, its production and use
JP5354680B2 (ja) Ｍｍｐ１３に対する中和活性を有するモノクローナル抗体
WO1998010292A1 (fr) Anticorps monoclonaux contre l'antigene prostatique specifique et procedes de detection de l'antigene prostatique specifique
JPH10287700A (ja) 活性型マトリライシン（ｍｍｐ−７）に対する抗体及びそれを用いた免疫学的測定法
JPWO2006004207A1 (ja) 抗シノビオリン抗体
US5858685A (en) Prostate specific antigen from benign prostatic hyperplasia and its use in diagnosis
WO1998022509A1 (fr) Anticorps monoclonaux specifiques destines au complexe psa-act
Wan et al. Three immunoassays based on monoclonal antibodies specific for prostate specific antigen (PSA), α‐1‐antichymotrypsin (ACT), and the PSA–ACT complex
AU768549B2 (en) Monoclonal antibody against canine trypsin
US20040214246A1 (en) Antibodies against particular forms of propsa and use thereof in immunoassays
CA2165672C (fr) Anticorps specifiques pour la kallikreine glandulaire de la prostate de l'homme
AU2012203101B2 (en) Antibody against enzyme specifically cleaving von villebrand factor and assay system using the same
JPH03200066A (ja) 活性化ヒトプロテインｃの測定方法
MICHEL et al. Analysis of prostate specific antigen and α1-antichymotrypsin interaction using antipeptide monoclonal antibodies
JP2002112768A (ja) アンジオスタチン特異的モノクローナル抗体、及びこのモノクローナル抗体を用いたアンジオスタチンの検出方法等
CA2244941A1 (fr) Antigene prostatique specifique et leurs utilisations

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG US UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWE Wipo information: entry into national phase

Ref document number: 09254368

Country of ref document: US

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase

Ref country code: CA

NENP Non-entry into the national phase

Ref country code: JP

Ref document number: 1998512712

Format of ref document f/p: F

122 Ep: pct application non-entry in european phase